• Quick Order
  • Careers
  • Support

2023 News Releases

5DM40321 © David Galen.jpg November 30, 2023

ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs

ATCC announced a seven-year contract, with an initial award of over $21.5 million, from NIAID to continue the management of the newly merged NIH HIV Reagent Program with the BEI Resources Program.

New ATCC building entrance. November 28, 2023

ATCC Announces Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Award from NIAID

ATCC was awarded a Task Order under the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) to manage critical biomaterials for NIAID's Vaccine Research Center.

International Space Station orbiting Earth like planet November 10, 2023

ATCC Products to be Used in Microgravity Experiments on the International Space Station

ATCC catalog item MSA-2003-ISS was sent to the International Space Station (ISS National Lab) aboard the SpaceX CRS-29 mission.

Rows of vials sealed with silver and purple caps. November 07, 2023

ATCC Announces Award from NIAID to Support Its Preclinical Services for Biopharmaceutical Product Development

ATCC awarded an IDIQ contract by NIAID to support its preclinical services for biopharmaceutical product development.

New ATCC building entrance at night with lights. November 02, 2023

ATCC Appoints Dr. Alfredo Molinolo to Its Board of Directors

Dr. Molinolo's strong research background and extensive expertise in pathology, oncology, and histotechnology will make him a tremendous asset to ATCC.

08. Scientists DNA Particles_7680x4320.png October 30, 2023

ATCC and USP Launch First Set of Products to Advance Quality and Reduce Risk in the Development of Biological Therapeutics and Vaccines

ATCC and USP launch six new products that can be used to detect residual host cell genomic DNA (gDNA)

Scientist wearing safety mask, smock, and gloves removing stock from cryo tank in repository. June 27, 2023

ATCC Announces New Award from BARDA to Further Support its Medical Countermeasures Clinical Studies Network

ATCC announced task order award from BARDA to serve as a centralized facility to support the storage and distribution of clinical samples and investigational products.

Scott Boller headshot March 21, 2023

ATCC Hires New Chief Financial Officer

As CFO, Mr. Boller will work with executive leadership to manage external reporting and auditing requirements, oversee major contracts, forecasting, budgeting of business operations, and serve as assistant treasurer of the Finance Committee of the Board of Directors.

Exterior of new ATCC building. February 23, 2023

ATCC and USP Enter Strategic Collaboration to Support Global Quality Production of Biologics

ATCC and USP announced a strategic collaboration to provide solutions and standards that help customers deliver safe and high-quality biologics to patients more rapidly.

New ATCC building entrance at dusk with lights. January 10, 2023

ATCC Announces Participation with Areté on IARPA Contract to Develop New Methods for Identifying Low-dose Radiation Exposure

ATCC announced that it would be supporting Areté, one of the four winning teams awarded a contract from IARPA, to develop novel methods for Targeted Evaluation of Ionizing Radiation Exposure (TEI-REX).